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A b s t r a c t
Introduction: Proton radiation offers physical advantages over conventional 
radiation. Radiosensitivity of human 59M ovarian cancer and HTB140 mela-
noma cells was investigated after exposure to γ-rays and protons. 
Material and methods: Irradiations were performed in the middle of a 62 MeV 
therapeutic proton spread out Bragg peak with doses ranging from 2 to 16 Gy. 
The mean energy of protons was 34.88 ±2.15 MeV, corresponding to the 
linear energy transfer of 4.7 ±0.2 keV/μm. Irradiations with γ-rays were per-
formed using the same doses. Viability, proliferation and survival were as-
sessed 7 days after both types of irradiation while analyses of cell cycle and 
apoptosis were performed 48 h after irradiation. 
Results: Results showed that γ-rays and protons reduced the number of vi-
able cells for both cell lines, with stronger inactivation achieved after irra-
diation with protons. Surviving fractions for 59M were 0.91 ±0.01 for γ-rays 
and 0.81 ±0.01 for protons, while those for HTB140 cells were 0.93 ±0.01 
for γ-rays and 0.86 ±0.01 for protons. Relative biological effectiveness of 
protons, being 2.47 ±0.22 for 59M and 2.08 ±0.36 for HTB140, indicated that 
protons provoked better cell elimination than γ-rays. After proton irradiation 
proliferation capacity of the two cell lines was slightly higher as compared 
to γ-rays. Proliferation was higher for 59M than for HTB140 cells after both 
types of irradiation. Induction of apoptosis and G2 arrest detected after 
proton irradiation were more prominent in 59M cells.
Conclusions: The obtained results suggest that protons exert better antitu-
mour effects on ovarian carcinoma and melanoma cells than γ-rays. The dis-
similar response of these cells to radiation is related to their different features.
Key words: apoptosis, cell cycle, γ-rays, melanoma, protons, ovarian 
carcinoma.
Introduction
Ionizing radiation initiates diverse biochemical processes that deter-
mine the cellular response. DNA repair mechanisms, cell cycle arrest and 
apoptosis are probably the most important biological events [1]. Radia-
tion therapy is among first-line treatments in curing cancer [2]. However, 
it is well known that various tumours respond differently to the same 
type of treatment. For example, lymphomas and leukaemias are gener-
ally highly radiosensitive, squamous cell carcinomas show intermediate 
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sensitivity, while melanomas are considered to be 
the most resistant to radiation therapy, as well as 
to other therapeutic agents [3–5]. The same type 
of treatment can induce different responses even 
among tumours of the same histological type [6]. 
This differential sensitivity of the tumour cells and 
their ability to recover from radiation damage ex-
plains why conventional radiation therapy can be 
successfully used to control certain types of tu-
mours, while having less success in others [7]. 
DNA is widely recognized to be the most im-
portant target for ionizing radiation. Thus, expo-
sure to radiation results directly in DNA injuries 
or indirectly by ionizing cellular water molecules 
to produce free radicals that are involved in the 
DNA damage [1]. Various types of cytotoxic DNA 
lesions induced by ionizing radiation are classi-
fied into DNA double-strand breaks (DSBs), DNA 
single-strand breaks (SSBs), DNA adducts and 
DNA-protein cross-links [8]. The DNA DSBs are 
generally considered to be critical DNA lesions 
with greater biological significance than SSBs. They 
have important biological consequences such as 
cell death, chromosome aberration and loss of ge-
netic information [9]. 
The aim of radiation therapy is to kill tumour 
cells and to avoid damage of the neighbouring 
normal tissue. Proton radiation offers several 
advantages over conventional photon radiation 
including the ability to deliver much higher spe-
cific energy loss per unit length, i.e. linear ener-
gy transfer (LET), precisely to the tumour volume, 
while sparing the surrounding healthy tissue [10]. 
Due to the physical properties of protons maxi-
mum ionization is achieved at the precisely con-
trolled position, just before the end of the range, 
which is known as the Bragg peak. In order to de-
liver a uniform dose to the entire tumour volume 
the Bragg peak is spread out by modifying proton 
energy at the price of a moderately increased en-
trance dose [11]. The relative biological effective-
ness (RBE) reflects biological effectiveness of the 
specific type of ionizing radiation in comparison 
to the reference radiation. 
In this study, the level of cellular response of 
irradiated human 59M ovarian cancer and hu-
man HTB140 melanoma cells was investigated 
and compared using assays for the assessment of 
cell viability, proliferation, cell cycle and apoptosis. 
Inactivation effects of the two different radiation 
qualities, γ-rays and protons, were analysed for 
each cell line. 
Material and methods
Cell culture
The human 59M and HTB140 cells were pur-
chased from the American Tissue Culture Collec-
tion (Rockville, MD, USA) and routinely maintained 
as a  monolayer in RPMI1640 medium supple-
mented with 10% fetal bovine serum, penicillin/
streptomycin and L-glutamine (all from Sigma-Al-
drich Chemie GmbH, Steinheim, Germany) under 
standard conditions at 37°C in humidified atmo-
sphere with 5% CO2 (Heraeus, Hanau, Germany).
Irradiation conditions
Proton irradiations were performed within the 
spread-out Bragg peak (SOBP) of the 62 MeV ther-
apeutic proton beam produced by the supercon-
ducting cyclotron at the CATANA (Centro di Adro 
Terapia e Applicazioni Nucleari Avanzate) treat-
ment facility in the Istituto Nazionale di Fisica Nu-
cleare (INFN), Laboratori Nazionali del Sud (LNS) in 
Catania, Italy. Irradiation position was in the mid-
dle of the SOBP. This was achieved by interposing 
a 16.3 mm thick Perspex plate (polymethyl meth-
acrylate – PMMA) between the final collimator and 
cell monolayer, thus obtaining a corresponding rel-
ative dose of 99.42 ±0.58%. The mean energy of 
protons was 34.88 ±2.15 MeV, corresponding to 
the LET of 4.7 ±0.2 keV/μm. Reference dosimetry 
was performed using a plane-parallel PTW 34045 
Markus ionization chamber calibrated according 
to International Atomic Energy Agency technical 
Report series (IAEA 2000) code of practice [12, 13]. 
Single doses delivered to the cells were 2, 4, 8, 12 
and 16 Gy, at the dose rate of 15 Gy/min. 
Irradiations with 60Co γ-rays at the same dose 
level and with the dose rate of 1 Gy/min were per-
formed at the Vinča Institute of Nuclear Sciences, 
Belgrade, Serbia. All irradiations were carried out 
in air at room temperature. Cell viability and cell 
proliferation assays were performed 7 days after 
irradiation under standard conditions. The results 
were presented as the percentage of control val-
ues. Cell cycle distribution and induction of apop-
tosis were evaluated 48 h after irradiation.
Cell viability assays
Cell viability was estimated 7 days after irradi-
ation using Cell Proliferation Kit I, MTT (Roche Di-
agnostics GmbH, Mannheim, Germany) according 
to the manufacturer’s procedure. The absorbance 
was measured using a microplate reader (Wallac, 
VICTOR2 1420 Multilabel counter, PerkinElmer, 
Turku, Finland) at a  test wavelength of 550 nm 
and a reference wavelength of 690 nm. 
The sulforhodamine B (SRB) assay, based on the 
measurement of cellular protein content, was used 
for cell density determination. Cells were seeded 
in 96-well plates (NunclonTM, Roskilde, Denmark), 
at the appropriate concentration. After 7 days of 
post-irradiation incubation, cell monolayers were 
fixed with 10% trichloroacetic acid (TCA) for 1 h 
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at 4°C. Plates were then washed with water and 
stained with 0.4% SRB (Sigma-Aldrich Chemie 
GmbH) in 1% acetic acid for 15 min at room tem-
perature. Excess stain was removed by washing 
repeatedly with 1% acetic acid. Plates were than 
air dried and the protein-bound dye was dissolved 
in 10 mM Tris base solution for 5 min. Absorbance 
was measured at 550 nm and a  reference wave-
length of 690 nm using a microplate reader (Wal-
lac, VICTOR2 1420 Multilabel counter). 
Cell proliferation assays
The DNA synthesis and cell proliferation were 
estimated using a 5-bromo-2-deoxyuridine (BrdU) 
assay (Roche Diagnostics GmbH). Cells were irra-
diated and incubated for 7 days before determina-
tion of cell proliferation according to the manufac-
turer’s instructions. The absorbance was measured 
using a microplate reader at a test wavelength of 
450 nm and a  reference wavelength of 690 nm 
(Wallac, VICTOR2 1420 Multilabel counter). 
Survival assay
For the evaluation of survival after irradiation 
the cells were harvested by trypsinization, seeded 
into 25 cm2 flasks at a suitable number and incu-
bated at 37°C for 7 days. Subsequently, the cells 
were fixed with methanol and stained with 10% 
Giemsa solution. Groups of at least fifty cells were 
scored as individual colonies.
Flow cytometric analysis of cell cycle
For the flow cytometric evaluation of the cell 
cycle status 1 × 106 cells were taken from each 
flask, washed with phosphate buffered saline 
(PBS), fixed overnight with 70% cold ethanol and 
stained with PBS buffer that contained 50 μg/ml 
propidium iodide (PI) and 50 μg/ml RNase (both 
from Sigma-Aldrich Chemie GmbH). After incuba-
tion at room temperature for 30 min, cells were 
analysed by flow cytometry (FACSCalibur; Becton 
Dickinson, USA) using ModFit software. 
Flow cytometric analysis of apoptosis
For quantification of the apoptotic cells, flow cy-
tometric analysis with the Annexin V-FLUOS Stain-
ing kit (Roche Diagnostics GmbH) was performed 
according to the manufacturer’s instructions. Cells 
were trypsinized, washed in ice-cold PBS and re-
suspended in 100 μl Annexin V-Fluos labelling 
solution (containing Annexin V-Fluos labelling re-
agent and PI). After their incubation in the dark for 
30 min, 500 μl of an incubation buffer was added 
per sample. Samples were analysed on a  FACS-
Calibur cytometer (Becton Dickinson). For each 
sample, 10 000 cells were analysed. The number 
of apoptotic cells was calculated using the ModFit 
software (Verity Software, Becton Dickinson). 
Statistical analysis
Quadruplicate measurements were made during 
each experiment, and all experiments were repeat-
ed at least twice. Independent Student’s t-test was 
performed to assess the significance of differences 
among analysed experimental groups. The level of 
significance was set at p < 0.05. Results were pre-
sented as the mean ± SD (standard deviation).
Results 
Effects of γ-rays and protons on cell viability
Exponentially growing 59M and HTB140 cells 
were irradiated with single doses (2 to 16 Gy) of 
γ-rays and protons. To compare inactivation abil-
ity of relatively high LET proton irradiation with 
γ-rays, the level of cell viability was measured 
7 days after irradiation by MTT and SRB tests, as 
well as by clonogenic assay. 
The viability data for the 59M cells obtained by 
MTT assay revealed good dose-dependent inhibi-
tory effects for both types of radiation. However, 
better inactivation was detected after proton ir-
radiation (p < 0.05 for 16 Gy). According to the 
MTT assay cell viability ranged from 88% to 47% 
for γ-rays (p < 0.05 for 2 Gy, p < 0.001 for higher 
doses) and from 82% to 32% for protons (p < 0.01 
for 2 Gy, p < 0.001 for higher doses), as shown in 
Figure 1 A. Cell viability evaluated by SRB assay 
and presented in Figure 1 B was in the interval 
from 94% to 71% for γ-rays (p < 0.05 for 4 Gy, 
p < 0.001 for higher doses) and from 86% to 51% 
for proton irradiation (p < 0.01 for 2 Gy, p < 0.001 
for higher doses). The SRB assay also showed bet-
ter dose-dependent inhibitory effects after proton 
irradiation as compared to γ-rays (p < 0.05 for 
12 and 16 Gy). These results indicated that the 
SRB assay provided somewhat higher values as 
compared to MTT.
Very good agreement of dose-dependent via-
bility data was obtained between MTT and SRB 
assays for the HTB140 cells. Estimated cell via-
bility assessed by MTT was from 87% to 63% af-
ter γ-rays (p < 0.05 for 2 Gy, p < 0.001 for higher 
doses), while for protons it was from 69% to 34% 
(p < 0.001), and is shown in Figure 2 A. The values 
obtained by SRB assay, which are given in Figure 2 B, 
ranged from 85% to 74% after γ-rays (p < 0.01 for 
2 Gy, p < 0.001 for higher doses) and from 72% to 
40% after proton irradiation (p < 0.001). A stron-
ger dose-dependent radiation response was ob-
tained by both assays after proton irradiation 
than after γ-rays (p < 0.001).
Results obtained for the two cell lines by clono-
genic assay that was performed 7 days after irradia-
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tions with protons and γ-rays are presented in Fig - 
ure 3. Survival data were fitted using the linear-qua-
dratic equation: S = exp (– α D – β D2), where S is 
the surviving fraction for the dose D, while α and 
β are fitting parameters. The values of fitting pa-
rameter α, coefficient of determination (r2) and fit 
standard error are given in Table I. Due to very low 
values, parameter β is not included in Table I.
The fitted curves revealed that the level of cell 
inactivation produced by proton irradiation was 
higher than that of γ-rays for both cell lines. The 
killing capacity of both radiation types was more 
pronounced for the 59M cells (Figure 3 A) than for 
the HTB140 cells (Figure 3 B). Surviving fractions at 
2 Gy, i.e. SF2 values, reflecting the level of cellular ra-
diosensitivity, were obtained from the fitted curves 
and are given in Table I. According to these results 
the SF2 values for the ovarian 59M cells were 0.91 
±0.01 and 0.81 ±0.01 for γ-rays and protons, respec-
tively. The HTB140 cells expressed somewhat higher 
level of radioresistance, with the SF2 values of 0.93 
±0.01 for γ-rays and 0.86 ±0.01 for protons. 
The RBE values, defined as the ratio of 2 Gy 
γ-rays dose and the proton dose producing the 
same inactivation level as that given by 2 Gy of 
the reference γ-rays, were 2.47 ±0.22 for the 59M 
and 2.08 ±0.36 for the HTB140 cells (Table I). 
Effects of γ-rays and protons on cell 
proliferation
The effects of γ-rays and protons on cell prolif-
eration of 59M and HTB140 cells are presented in 
Figure 1. Effects of γ-rays and protons on 59M cell viability 7 days after irradiation, estimated by MTT (A) and 
SRB assays (B). Data obtained from 4 experiments are presented as means ± SD. Irradiation doses were 2–16 Gy
*Statistical significance compared to the control, #statistical significance compared to γ-rays; *, #0.01 < p < 0.05, **, ##0.001 < p < 
0.01, ***, ###p < 0.001
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Figure 2. Effects of γ-rays and protons on HTB140 cell viability 7 days after irradiation, estimated by MTT (A) and 
SRB assays (B). Data obtained from 4 experiments are presented as means ± SD. Irradiation doses were 2–16 Gy 
*Statistical significance compared to the control, #statistical significance compared to γ-rays, *, #0.01 < p < 0.05, **, ##0.001 < p < 0.01, 
***, ###p < 0.001
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Figure 4. There was a trend of a dose-dependent 
decrease of proliferation for each cell line after ex-
posure to the two radiation types.
Proliferation capacity of 59M cells was in the 
range from 80% to 45% for γ-rays (p < 0.001) and 
from 89% to 53% for protons (p < 0.05 for 2 Gy, 
p < 0.001 for higher doses). A  very pronounced 
dose-dependent decrease of proliferation was ob-
served, having rather high values in the whole dose 
range (Figure 4 A). The level of cell proliferation 
of HTB140 cells was from 46% to 35% for γ-rays 
(p < 0.001) and from 50% to 44% for protons (p < 
0.001). The decrease of proliferation with dose was 
minor with rather low values for all doses (Figure 4 B).
Effects of γ-rays and protons on cell cycle 
and apoptosis
In order to obtain an in-depth picture of anti- 
tumour effects of γ-rays and protons, cell cycle 
and apoptosis were investigated. Since the dose 
of 8 Gy of proton radiation inhibited survival of 
analysed cell lines close to 50%, this dose was 
chosen for the analyses. Literature data suggested 
that for the majority of cells apoptosis occurs after 
one or more cell divisions. Usually the maximum 
number of apoptotic cells in in vitro conditions can 
be found 48 h after irradiation [14]. Based on this 
fact, the time point of 48 h after treatment was 
selected for the assessment of apoptosis in this 
study. Accordingly, changes in cell cycle distribu-
tion were determined at the same time point.
Both types of radiation induced an increase of 
G2 cell population in 59M cells as compared to 
untreated control (p < 0.05 for protons). This was 
followed by a reduction of S phase. More promi-
nent changes were observed after irradiation with 
protons (Figure 5 A). Similar trends were found in 
irradiated HTB140 melanoma cells (Figure 5 B).
Figure 3. Dose-response curves of 59M cells (A) and HTB140 cells (B) exposed to γ-rays and protons, obtained by 
clonogenic assay. Irradiation doses were 2–16 Gy. Data obtained from 4 experiments are presented as means ± SD
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Table I. Fitting parameters, SF2 and RBE (2 Gy, γ) for 59M and HTB140 cells after irradiation with γ-rays and protons
Irrad. type α(Gy–1) r2 Fit Std. Err. SF2 RBE (2 Gy, γ)
59M
γ-Rays 0.043 ±0.012 0.92 0.06 0.91 ±0.01 1.00
Protons 0.101 ±0.015 0.89 0.10 0.81 ±0.01 2.47 ±0.22
HTB140
γ-Rays 0.036 ±0.009 0.93 0.05 0.93 ±0.01 1.00
Protons 0.073 ±0.012 0.80 0.12 0.86 ±0.01 2.08 ±0.36
r2 – coefficient of determination = 1 – sum of squares about the mean/sum of squared errors. Results are presented as the mean ± 
standard deviation
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The obtained results indicated that γ-rays did 
not induce a  significant increase of apoptosis in 
either 59M or HTB140 cells. However, proton ra-
diation showed a better pro-apoptotic effect than 
γ-rays (p < 0.001 for 59M, p < 0.01 for HTB140 
cells). The percentage of induced apoptosis after 
irradiation with protons was 22% in 59M cells 
(p < 0.001, as compared to control), and 18% in 
HTB140 cells (p < 0.001, as compared to control) 
(Figure 6). 
Discussion
Many assays have been developed for the pre-
diction of individual radiosensitivity of tumour 
cells, but they have practical limitations. Despite 
disadvantages of the clonogenic assay such as its 
long duration and limitations with respect to the 
ability of cells to form colonies, the clonogenic as-
say is still considered to be the “gold standard” 
for the evaluation of cellular radiosensitivity [15]. 
The colorimetric microtetrazolium (MTT) assay 
is based on the ability of viable cells to reduce 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoli-
um bromide, a soluble yellow tetrazolium salt into 
blue-purple formazan crystals, thus overcoming 
the need for cells to form colonies. However, this 
behaviour is not linear at high cell densities [16]. 
Moreover, the SRB protein binding assay based on 
quantifying total protein content of viable cells 
Figure 4. Dose-dependent cell proliferation of 59M cells (A) and HTB140 cells (B) estimated by BrdU assay. Data 
obtained from 4 experiments are presented as means ± SD. Irradiation doses were 2–16 Gy
*Statistical significance compared to the control, #statistical significance compared to γ-rays, *, #0.01 < p < 0.05, **, ##0.001 < p < 
0.01, ***, ###p < 0.001
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Figure 5. The effects of γ-rays and proton radiation on cell cycle distribution in 59M (A) and HTB140 (B) cell line, 
estimated by flow cytometry 48 h after irradiation. Irradiation dose was 8 Gy. Data obtained from 4 experiments 
are presented as means ± SD
*Statistical significance compared to the control, #statistical significance compared to γ-rays, *, #0.01 < p < 0.05, **,##0.001 < p < 0.01, 
***, ###p < 0.001
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has some advantages over the MTT assay, such 
as higher sensitivity and linearity even at great-
er cell densities [17]. Unlike the MTT, the results 
obtained with the SRB assay are independent of 
metabolic conditions of the cells [18]. In addition, 
the BrdU assay, designed to follow DNA replica-
tion, is frequently used to assess proliferation ca-
pacity of irradiated cells [19].
Comparing the two cell lines, MTT and SRB 
assays detected a  rather similar response after 
proton irradiation, while the dose-dependent 
response after γ-rays appears to be more pro-
nounced for the 59M cells. Although having the 
same dose-dependent trend in the cell inactiva-
tion, certain differences in the results obtained 
by MTT and SRB were observed. Different criteria 
that are used in determination of cell viability by 
these two assays could be responsible for these 
differences. The MTT assay detects just living cells 
because it records only the cells with preserved 
mitochondrial function. In contrast, the SRB assay 
measures the total protein content and is inde-
pendent of metabolic conditions of the cell line. 
This assay does not need specific optimization for 
each individual cell line [20]. Therefore, slightly 
lower cell inactivation that was detected by SRB 
could be explained by possible presence of the 
proteins coming from the dead cells. 
According to the SF2 values acquired from the 
fitted curves, the HTB140 cells have a higher level 
of radioresistance to γ-rays and protons than the 
59M cell line. Still, both cell lines are among very 
radioresistant cells. Within each cell line protons 
were more efficient in cell inactivation than γ-rays, 
as illustrated by the corresponding RBE values. 
Moreover, the RBE of the 59M cells was greater 
than that of the HTB140 cells, which is due to 
stronger elimination of the 59M cells by protons. 
Very high radioresistance of HTB140 cells was 
discussed in a previous radiosensitivity study [4, 
11, 21]. The SF2 values obtained for the HTB140 
cells indicated that these cells are very high on the 
radiosensitivity scale reported for other cell lines 
[22]. A  similar level of radioresistance to γ-rays 
was reported for three human ovarian cell lines 
[23]. Moreover, the level of radioresistance of the 
HTB140 cells was almost the same when com-
pared to data reported for the U1 human bladder 
carcinoma cell line [24].
Analysing simultaneously the results of cell sur-
vival and proliferation within each cell line, it is ap-
parent that they have a decreasing trend with the 
rise of the applied doses. Although it may seem 
contradictory that in the case of survival protons 
produce stronger cell elimination than γ-rays, 
while cell proliferation is somewhat higher for pro-
tons than for γ-rays, such behaviour is consistent 
with the physical properties of γ-rays and protons, 
i.e., LET and track structure [25]. Proton irradia-
tion, due to large LET, is considered as high ion-
izing radiation and performs better cell elimina-
tion with respect to γ-rays. As shown in Figure 3, 
protons have stronger killing capacity, producing 
more irreparable and less reparable lesions than 
γ-rays. Due to their sparse truck structure γ-rays 
produce more reparable lesions leading to slight-
ly lower cell proliferation as compared to protons 
(Figure 4). Rather different distribution of cell pro-
liferation with the rise of the doses, for the two 
cell lines, is based on their dissimilar nature and 
some distinction in their radiosensitivity [11].
Growth inhibition of irradiated ovarian carci-
noma and melanoma cells, particularly observed 
after irradiation with protons, can be ascribed at 
least partially to changes in cell cycle distribution 
and apoptosis. Namely, in both analysed cell lines, 
G2 arrest typical for irradiated cells was observed, 
with a  significant increase noticed in 59M cells. 
This arrest is the outcome of radiation-induced 
DNA double strand breaks (DSBs). In our previ-
ous study [26] induction of DSBs in HTB140 mel-
anoma cells irradiated with γ-rays was analysed 
through evaluation of phosphorylation of histone 
H2AX in a  time-dependent manner. Within this 
study expression of p21 protein was also inves-
tigated. Phosphorylation of H2AX increased af-
ter irradiation, reaching the highest value at 2 h 
after irradiation. Prolongation of post-irradiation 
incubation caused a reduction of phosphorylated 
H2AX to the pre-irradiation level with a simultane-
ous increase of p21 protein. Since p21 is involved 
in the regulation of G1, as well as G2 arrest [27], 
these data imply that such behaviour is one of the 
Figure 6. The effects of γ-rays and proton radi-
ation on apoptosis in 59M and HTB140 cell line, 
estimated by flow cytometry 48 h after irradiation. 
Irradiation dose was 8 Gy. Data obtained from  
4 experiments are presented as means ± SD
*Statistical significance compared to the control, #statistical 
significance compared to γ-rays, *,#0.01 < p < 0.05, **,##0.001  
< p < 0.01, ***,###p < 0.001
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causes of G2 arrest. Given that protons have high-
er LET than γ-rays, with an RBE value ~2, they in-
duce higher numbers of DSBs in analysed cell lines 
and consequently more pronounced G2 block, as 
observed in our results presented herein. 
An increased number of apoptotic cells was de-
tected in both cell lines after proton irradiation. 
A more detailed radiation-induced mechanism of 
apoptosis, including changes in p53, Bax, Bcl-2 and 
PARP protein, as well as activation of caspase-3, 
was previously reported [28, 29]. Observed induc-
tion of apoptosis was in the range characteristic 
for other melanoma and ovarian carcinoma cells 
[30, 31] and confirms the high level of radioresis-
tance of analysed cell lines. 
In conclusion, the two human cancer cell 
lines 59M ovarian and HTB140 melanoma cells 
revealed high levels of cellular radioresistance 
to γ-rays and protons. Still, HTB140 melanoma 
cells displayed a higher level of radioresistance, 
thus being among extremely resistant cell lines. 
Obtained radiobiological results indicated that 
protons, due to their high LET, are superior in 
cell inactivation compared to γ-rays. Due to the 
different nature of the cells, after irradiation 
with γ-rays and protons, the 59M cells showed 
stronger proliferation, as well as a  higher level 
of apoptosis and more prominent G2 arrest than 
the HTB140 cells. 
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